4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide has been researched along with Obesity in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Futenma, A; Iwata, K; Kusunoki, M; Miyata, T; Mizutani, K; Nakamura, T; Nomura, T; Ogawa, H; Tsutsumi, K; Utsumi, K; Yin, W | 1 |
| Doi, M; Kano, S | 1 |
| Harada, N; Hattori, A; Hosaka, T; Li, Q; Lian, X; Mawatari, K; Nakamura, A; Nakano, M; Nakaya, Y; Shimohata, T; Takahashi, A; Wu, Q; Yoshida, M | 1 |
3 other study(ies) available for 4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide and Obesity
| Article | Year |
|---|---|
NO-1886 (ibrolipim), a lipoprotein lipase activator, increases the expression of uncoupling protein 3 in skeletal muscle and suppresses fat accumulation in high-fat diet-induced obesity in rats.
Topics: Adipose Tissue; Animals; Anti-Obesity Agents; Benzamides; Blood Glucose; Carrier Proteins; Dietary Fats; Eating; Gene Expression Regulation; Insulin; Ion Channels; Lipoprotein Lipase; Male; Mitochondrial Proteins; Muscle, Skeletal; Obesity; Organophosphorus Compounds; Rats; Rats, Sprague-Dawley; RNA, Messenger; Uncoupling Protein 3; Weight Gain | 2005 |
NO-1886 (ibrolipim), a lipoprotein lipase-promoting agent, accelerates the expression of UCP3 messenger RNA and ameliorates obesity in ovariectomized rats.
Topics: Adipose Tissue, Brown; Animals; Benzamides; Blood Glucose; Body Weight; Carrier Proteins; Eating; Fatty Acid Transport Proteins; Fatty Acid-Binding Proteins; Female; Gene Expression; Hypolipidemic Agents; Insulin; Ion Channels; Leptin; Mitochondrial Proteins; Muscle, Skeletal; Myocardium; Obesity; Organophosphorus Compounds; Ovariectomy; Oxygen Consumption; Proton-Translocating ATPases; Random Allocation; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Uncoupling Protein 3 | 2006 |
NO-1886, a lipoprotein lipase activator, attenuates contraction of rat intestinal ring preparations.
Topics: Animals; Benzamides; Calcium; Diabetes Mellitus, Type 2; Gastrointestinal Motility; Hypolipidemic Agents; In Vitro Techniques; Intestinal Diseases; Intestines; Lipoprotein Lipase Activators; Male; Muscle Contraction; Muscle, Smooth; Myosin-Light-Chain Kinase; Obesity; Organophosphorus Compounds; Peptides; Rats; Rats, Inbred OLETF; Rats, Wistar | 2008 |